Your Valley flags a big problem with a GLP-1 program. Details aren't given in the listing, so tap through for what went wrong.
Recap by typeshit. Full story at Your Valley.
The MFDS approval rests on SURPASS-CVOT, where Mounjaro matched Trulicity on heart events in 13,000+ patients but did not prove superior.
Inside Retail Asia looks at skincare and aesthetic treatments brands are building for facial volume loss after rapid weight loss.
The actor told an interviewer people can take Ozempic carefree, while stressing that nothing replaces actually working out.
CFO MV Narasimham says the company still expects to ship 6 to 7 million pens across 10 approved markets between November and March, with Canada taking most of them.
A weightlifter describes months of fatigue and twitching after BPC-157, as HHS pushes to ease limits on six peptides FDA scientists flagged for risks.
29:58
Meg takes her weekly tirzepatide shot on camera and steps on the scale to share where her weight loss stands so far.
Loading…